• +1 513 549 5911 (U.S.)
  • +44 203 318 2846 (U.K.)

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports

Peptide Cancer Vaccine Market

Global Peptide Cancer Vaccine Market Is Segmented On The Basis Of Pipeline Phase- Preclinical Research, Phase I, Phase II, Phase III And Research, On Basis Of Application - Breast Cancer, Prostate Cancer, Gastric Cancer, Pancreatic Cancer, Lung Cancer, Colorectal Cancer


Vaccines are the biological products that stimulate the immune system to protect the body against any foreign substance. The stimulated immune system destroys foreign particles and generates antibodies against it.  Vaccine memorizes foreign substance and prevents immunity from invading the body in future. Cancer vaccines are drug categorized as biological modifiers to response; they stimulate the immune system that can fight against the disorder. 

Peptide cancer vaccine creates a T-cell immune response, against tumor present in the body or it enhances pre-existing immune response against the tumor.  There are different types of immunotherapy for cancer treatment which include antibody-drug conjugates, dendritic cell-based vaccines, monoclonal-based immunotherapy and peptide-based cancer vaccines. Cancer vaccines are the most commonly used vaccines due to user-friendly nature of product, easy manufacturing process, and effective mechanism. Peptide cancer vaccines are used under various clinical research protocols for treatment of solid tumours.

The occurrence of chronic diseases such as cancer of various types such as breast cancer, prostate cancer, gastric cancer, pancreatic cancer, lung cancer, and colorectal cancer has increased the demand for vaccines which drives the peptide cancer vaccine market. Also, failure of methods to treat the disorder effectively has led the demand for new immunotherapy treatment. The major factors restraining the peptide cancer vaccine market include the need for the special storage facility, transportation of vaccines, and lack of cancer vaccines in the remote areas.

Regional Analysis:
Based on the regional analysis, the global peptide cancer market is segmented into North America, Europe, Asia-Pacific, and LAMEA. As per the estimation of National Cancer Institute, there were around 16.8 million new cases of cancer that were diagnosed in the U.S. in 2016, with approximately 6 lakhs deaths from the disorder. The number is expected to grow to 19 million by 2024. Several biotechnological and pharmaceutical companies are focusing on expanding into the Asia Pacific region to maximize the value of their research and development that will provide improved access to patients and provides low-cost operational efficiency to the manufacturers.

Business Intelligence:
Merck & Co. in May 2018 invested US$ 125 million in the Moderna Therapeutics. The expansion includes partnering of mRNA-5671. The vaccine includes mRNA for the four common KRAS mutation that will cover most of the mutation treatment which occur in pancreatic cancer, colorectal cancer and non-small cell lung cancer (NSCLC). Moderna launched Phase I KEYNOTE-603 study in November 2017 of mRNA-4157. Korean government in March 2011 participated in Korean National Enterprise for the Clinical Trials, advancement in the country’s infrastructure and conducting the clinical trials that are expected to launch peptide cancer vaccine in the market.

This report provides analysis of the peptide cancer vaccine market that contains current industry trends, market size, market growth and demands, major players with their key strategies. It covers growth opportunities and market canvas in the coming years. The report has been made with an in-depth analysis along with inputs from the various industry experts. The research has been carried out with primary and secondary data sources and either supporting bottom-up or top-down approach.

Major players:
Key players in the market are Immatics Biotechnologies, Galena Biopharma, Generex Biotechnology Corporation, BrightPath Biotherapeutics, BioLife Science, Lytix Biopharma, Antigen Express, Immune Design, Boston Biomedical and Enzo Life Science among others.

Global Composite Testing Market Segmentation:
Pipeline Phase

• Preclinical Research
• Phase I
• Phase II
• Phase III
• Research

By Application
• Breast Cancer
• Prostate cancer
• Gastric cancer
• Pancreatic cancer
• Lung cancer
• Colorectal Cancer

Regions Covered:
• North America (U.S and Canada and rest of North America)
• Europe (Germany, France, Italy and Rest of Europe)
• Asia-Pacific (China, Japan, India, South Korea and Rest of Asia-Pacific)
• LAMEA (Brazil, Turkey, Saudi Arabia, South Africa and Rest of LAMEA)


									

	

Related Reports

Global Drug of Abuse Testing Market-Forecast to 2024

The global drug of abuse testing market is projected to cross US$ 5 Billion by 2024. Drugs of abuse testing involves detection of one or more illegal and/or prescribed substances in the urine, blood, ...read more

United States Influenza Vaccines Market Report, Analysis and Forecast to 2025

United States Influenza Vaccines market is set to touch US$ 3.5 Billion threshold by 2025. “United States Influenza Vaccines Market Report, Analysis and Forecast to 2025” presents an in-depth ass ...read more

Global Platelet Agitators Market Study and Trend Research 2015-2025

Snapshot The global Platelet Agitators market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025. Product Type Coverage (Market Size & Forecast, Major Company of Product Type ...read more

Global Pharmaceutical Grade Sodium Chloride Market Study and Trend Research 2015-2025

Snapshot Sodium chloride (NaCl) is the chemical name for salt. Sodium chloride occurs naturally as the mineral halite. Commercially, it is obtained by the solar evaporation of salt water, or by mining ...read more

Global Pharmaceutical Autoclaves Market Study and Trend Research 2015-2025

Snapshot The global Pharmaceutical Autoclaves market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025. Product Type Coverage (Market Size & Forecast, Major Company of Produ ...read more

Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

How To Reach Us

Reach out to our most senior Sales Professional- Jay Matthews
   +1 513 549 5911 (US)
          +44 203 318 2846 (UK)
   sales@reportsmonitor.com

Our Clients

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
--Marketing Manager at a pharma company in Belgium

Enquire Before Buying

Need to ask a quick question before buying? Please fill out this short form:

Our Features

Wide Network of Publishers

Wide Network of Publishers

Access to over 1M+ market research reports

Trusted by the Best

Trusted by the Best

50+ Clients in Fortune 500

Competitive Pricing

Competitive Pricing

Our regular promotional offers and discounts make us the most economic seller of market reports

Safe and Secure

Safe and Secure

Your payment details are protected by us.